Seòmar agus comataidhean

Given the range of symptoms which can be presented by Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), we know there’s no ‘one-size fits all’ response. Our approach is to support people with ME/CFS to access care and support in a setting that is appropriate and as close to their home as practicable.

We are working to support and develop Scotland’s multi-disciplinary primary care workforce, and have increased the Primary Care Improvement Fund to recruit multi-disciplinary teams from £155 million in 2021-22 to £170 million in 2022-23. This will help towards giving people living with ME/CFS access to a wider range of healthcare professionals through their local practice.

In July 2022, we published a Scottish stakeholder review of the National Institute for Health and Care Excellence (NICE) guideline on ME/CFS. This review involved engaging with stakeholders to discuss how we implement the NICE guidance in Scotland and identify priorities for service improvement in ME/CFS care.

In June 2022 the National Clinical Director wrote to health boards , including primary care and AHP leads, and integration authorities to highlight:

• that the finalised NICE guideline on ME/CFS had been published
• key changes in recommended practice regarding Graded Exercise Therapy and Cognitive Behavioural Therapy
• key points from the NICE Implementation Support Statement.

Officials are partially updating the Scottish Good Practice Statement on ME/ Chronic Fatigue Syndrome to incorporate the key changes in practice from the NICE guideline and are currently working to publish this on the Scottish Government’s website.

The recommendations for the Scottish Government included within the Equality and Human Rights Commission report, Housing and Disabled People: Scotland’s Hidden Crisis are being taken forward as part of the implementation of our Housing to 2040 strategy published in 2021. The specific recommendations regarding Relevant Adjustments to Common Parts (Disabled Persons) (Scotland) Regulations 2020 and guidance to local authorities on setting targets for wheelchair accessible housing were completed in advance of the publication of Housing to 2040.

As part of delivery of the Housing to 2040 route map we will work with stakeholders to identify the most effective ways to match availability of accessible housing and demand from those who require an accessible home.

The Scottish Government has not carried out any analysis on the number of lung cancer cases that could be diagnosed sooner with a national screening programme, but has kept up to date with emerging evidence that led to the UK National Screening Committee’s recent recommendation to move towards the implementation of targeted screening programme for lung cancer in adults aged 55–74 with a history smoking.

I refer the member to the answer to question S6W-10989 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

I refer the member to the answer to question S6W-10787 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

I refer the member to the answer to question S6W-10787 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

Public Health Scotland publish figures on the uptake of COVID-19 vaccines by Scottish Index of Multiple Deprivation (SIMD) quintile. The PHS report shows how uptake in the most deprived areas compares with the least deprived areas. The latest figures were published in May 2022 ( https://publichealthscotland.scot/media/13184/22-05-11-covid19-publication_report.pdf ). The next publication is planned for later this year. This publication will contain uptake data by SIMD for COVID-19 autumn/winter 2022 vaccinations only; there will not be analysis on spring/summer COVID-19 boosters specifically.

I refer the member to the answer to question S6W-10787 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

I refer the member to the answer to question S6W-10787 on 3 October 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .